由于 ABCC8 和 KCNJ11 的激活突变导致的永久性新生儿糖尿病。
Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
机构信息
Institute of Biomedical and Clinical Science, Peninsula College of Medicine and Dentistry, University of Exeter, Barrack Road, Exeter, UK.
出版信息
Rev Endocr Metab Disord. 2010 Sep;11(3):193-8. doi: 10.1007/s11154-010-9149-x.
The ATP-sensitive potassium (K(ATP)) channel is composed of two subunits SUR1 and Kir6.2. The channel is key for glucose stimulated insulin release from the pancreatic beta cell. Activating mutations have been identified in the genes encoding these subunits, ABCC8 and KCNJ11, and account for approximately 40% of permanent neonatal diabetes cases. The majority of patients with a K(ATP) mutation present with isolated diabetes however some have presented with the Developmental delay, Epilepsy and Neonatal Diabetes syndrome. This review focuses on mutations in the K(ATP) channel which result in permanent neonatal diabetes, we review the clinical and functional effects as well as the implications for treatment.
三磷酸腺苷敏感性钾 (K(ATP)) 通道由 SUR1 和 Kir6.2 两个亚基组成。该通道是胰腺β细胞葡萄糖刺激胰岛素释放的关键。在编码这些亚基 ABCC8 和 KCNJ11 的基因中已发现激活突变,占永久性新生儿糖尿病病例的约 40%。大多数 K(ATP) 突变患者表现为孤立性糖尿病,但有些患者表现为发育迟缓、癫痫和新生儿糖尿病综合征。这篇综述重点介绍导致永久性新生儿糖尿病的 K(ATP) 通道突变,我们综述了其临床和功能影响以及对治疗的意义。